USPTO serial 78969024
EIRGEN
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 8, 2008
- Examiner
- SALEM-HOWEY, AISHA
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with EIRGEN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Elizabeth Atkins
ELIZABETH ATKINS LATHROP & GAGE LC230 PARK AVENUESUITE 1847NEW YORK, NY 10169-1304Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | chemicals used in industry, science and photography; chemical substances for preserving foodstuffs; adhesives used in industry; chemical products and reagents for use in biotechnology other than for medical or veterinary use; biological preparations for use in biotechnology other than for medical use | SECTION 8 - CANCELLED | — |
| 003 | cosmetic sun-tanning preparations; tanning creams | SECTION 8 - CANCELLED | — |
| 005 | Pharmaceutical preparations and substances for the treatment of medical ailments and medical conditions, namely, cardiovascular and central nervous system disorders, malignant diseases and immunosuppression, musculoskeletal and joint diseases, ocular, gynecological and urinary tract disorders and infectious and non-infectious diseases; sanitary preparations for medical use; prescription pharmaceutical and biotechnological preparations for the treatment of medical ailments and medical conditions, namely, cardiovascular and central nervous system disorders, malignant diseases and immunosuppression musculoskeletal and joint diseases, ocular, gynecological and urinary tract disorders and infectious and non-infectious diseases; biological preparations for medical purposes, namely for use in biotechnology; chemical preparations and reagents for use in biotechnology for medical and veterinary use; injectable solutions for medical purposes, namely, injectable pharmaceuticals for cardiovascular and central nervous system disorders, malignant diseases and immunosuppression, musculoskeletal and joint diseases, ocular, gynecological and urinary tract disorders; dietetic foods, food supplements, infusions, drinks and beverages all adapted for medical use; all purpose disinfectants, oral disinfectants for medical and hygienic purposes, disinfectants for hygienic and sanitary purposes, disinfectants for medical instruments; syrups for pharmaceutical purposes, namely cough syrups; vaccines; syringes containing pharmaceuticals for the treatment of cardiovascular and central nervous system disorders, malignant diseases and immunosuppression, musculoskeletal and joint diseases, ocular, gynecological and urinary tract disorders for medical use; pre-filled disposable syringes and hypodermic syringes containing pharmaceuticals for the treatment of cardiovascular and central nervous system disorders, malignant diseases and immunosuppression, musculoskeletal and joint diseases, ocular, gynecological and urinary tract disorders for medical use | SECTION 8 - CANCELLED | — |
| 010 | Surgical apparatus and instruments for use in general surgery and surgical procedures; medical apparatus and instruments for use in general surgery; dental surgical apparatus and instruments for use in a dental surgery; veterinary surgical apparatus and instruments for use in a veterinary surgery; orthopedic braces, footwear, belts, corsets, trousers, inserts for footwear and soles; orthopedic joint implants, supports and bandages; sutures; syringes for injections; disposable syringes; inhalers for medical use; injection instruments with needles for medical use; injection instruments without needles for medical use; medical and dental syringes | SECTION 8 - CANCELLED | — |
| 042 | The provision of information on the subject of research and development, drug development and product evaluation all in the field of pharmaceuticals and biotechnology; scientific and industrial research relating to pharmaceuticals and biotechnology | SECTION 8 - CANCELLED | — |
| 044 | Medical services; facial beauty treatment services; consultancy services relating to beauty; beauty salons; providing information on hygiene and beauty; providing health information services | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by EirGen Pharma Limited
- Other trademarks owned by EirGen Pharma Limited
- Other trademarks owned by EirGen Pharma Limited
- Other trademarks in Class 001
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named EIRGEN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 15, 2014 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Jan 8, 2008 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 23, 2007 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 3, 2007 | NPUB | NOTICE OF PUBLICATION | — |
| Sep 19, 2007 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Sep 19, 2007 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 19, 2007 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 19, 2007 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 19, 2007 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 19, 2007 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 18, 2007 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Sep 18, 2007 | PBSR | WITHDRAWN FROM PUB - SENIOR ATTORNEY REQUEST | — |
| Sep 5, 2007 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Aug 31, 2007 | ALIE | ASSIGNED TO LIE | — |
| Aug 31, 2007 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 31, 2007 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 31, 2007 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 31, 2007 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 31, 2007 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 2, 2007 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Aug 2, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 1, 2007 | ALIE | ASSIGNED TO LIE | — |
| Jul 16, 2007 | FAXX | FAX RECEIVED | — |
| Feb 1, 2007 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 1, 2007 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 31, 2007 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 13, 2006 | NWAP | NEW APPLICATION ENTERED | — |